Evaluating only Medicapp’s profile at its peak — without knowing the outcome — the model ranked Regulation as the #1 likely cause. Documented cause: Unit economics.
Key Events Timeline
FOUNDING
Medicapp founded in Mexico City with angel funding for doctor booking platform.
PRODUCT LAUNCH
Reached 5,000 registered doctors and 200,000 patients; unable to convert to paid model.
PIVOT
COVID boosted telemedicine usage but Doctoralia and Teladoc captured the surge.
SHUTDOWN
Operations ceased after Series A fundraise failed; platform taken offline.
Full Analysis
Free · no account needed
Documented cause
Medicapp was a Mexico-based telemedicine and doctor-appointment booking platform that launched in 2015 with backing from Mexican angel investors. Despite growing to 5,000 registered doctors and 200,000 patient users by 2019, the company struggled to monetize: doctors resisted subscription fees and patients expected free consultations. COVID briefly boosted usage but larger players like Doctoralia and Teladoc absorbed the market. Medicapp ceased operations in 2021 after failing to raise a Series A.
Lesson
“Healthcare marketplaces must lock in monetization before scaling users; free usage creates fatal pricing resistance later.”